55.3K(top 0.1%)
papers
1.2M(top 0.1%)
citations
315(top 0.1%)
h-index
546(top 0.1%)
g-index
64.3K
all documents
1.3M
doc citations
29.7K
citing journals

Top Articles

#TitleJournalYearCitations
1Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal studyScientific Reports20219,439
2Sarcopenia: European consensus on definition and diagnosisAge and Ageing20109,132
3Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology20118,001
4Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung CancerNew England Journal of Medicine20157,261
5Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy20164,701
62013 ESH/ESC Guidelines for the management of arterial hypertensionJournal of Hypertension20134,251
7Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionNew England Journal of Medicine20194,108
8EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateAnnals of the Rheumatic Diseases20173,366
9Guidelines for the use and interpretation of assays for monitoring autophagyAutophagy20123,122
10EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology20152,445
11Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal20132,436
12The Chlamydomonas Genome Reveals the Evolution of Key Animal and Plant FunctionsScience20072,354
13Improved Overall Survival in Melanoma with Combined Dabrafenib and TrametinibNew England Journal of Medicine20152,240
14Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyLancet Oncology, The20102,093
15Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseNew England Journal of Medicine20132,001
16A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsNature Medicine20001,945
17MosesNature Medicine20071,900
18CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) GroupLancet Oncology, The20061,840
19Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine20091,781
20LSST: From Science Drivers to Reference Design and Anticipated Data ProductsAstrophysical Journal20191,744
21EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnnals of the Rheumatic Diseases20141,688
22Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialLancet, The20131,664
23Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’European Heart Journal20101,637
24EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology20171,594
25European Position Paper on Rhinosinusitis and Nasal Polyps 2020Rhinology20201,555
26Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I TrialGastroenterology20061,523
27Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck CancerNew England Journal of Medicine20071,522
28Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1Autophagy20211,430
29EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases20101,429
30International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With CancerJournal of Clinical Oncology20141,380
31The Revised Classification of EukaryotesJournal of Eukaryotic Microbiology20121,340
32Rosuvastatin in Older Patients with Systolic Heart FailureNew England Journal of Medicine20071,330
33A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusArthritis and Rheumatism20111,277
34Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trialLancet, The20191,274
352019 update of the EULAR recommendations for the management of systemic lupus erythematosusAnnals of the Rheumatic Diseases20191,265
36ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imagingBioinformatics20141,252
37Estimation of nuclear DNA content in plants using flow cytometryNature Protocols20071,219
38Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revisionJournal of Allergy and Clinical Immunology20171,199
39Population genomics of Bronze Age EurasiaNature20151,166
40EAU Guidelines on Interventional Treatment for UrolithiasisEuropean Urology20161,166
41Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumoursJournal of Pathology20141,151
42Riociguat for the Treatment of Chronic Thromboembolic Pulmonary HypertensionNew England Journal of Medicine20131,144
432016 updated EULAR evidence-based recommendations for the management of goutAnnals of the Rheumatic Diseases20171,096
44Introduction to multi-layer feed-forward neural networksChemometrics and Intelligent Laboratory Systems19971,092
45Analysis of shared heritability in common disorders of the brainScience20181,085
46Antioxidant and prooxidant properties of flavonoidsFìtoterapìâ20111,084
47ppCollisions ats=7and 8 TeV with the ATLAS and CMS Experiments">Combined Measurement of the Higgs Boson Mass inppCollisions ats=7and 8 TeV with the ATLAS and CMS ExperimentsPhysical Review Letters20151,062
48EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013European Urology20131,053
49Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialLancet, The20121,041
50Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialLancet, The20121,040